Clinical Practice Outcomes With Lecanemab for Alzheimer Disease

Andy J. Liu, Alexander A. Moghadam, Mohammad Samsul Alam, Michael W. Lutz, Amber Navarra, Sheng Luo, Laura A. Wang, Jeffrey R. Petrella, Heather Whitson, Richard J. O'Brien, Kim G. Johnson, Daniel Parker, Cynthia Beam, Michelle Sanfilippo, Heba Al-Sahlani, Sandra Cobb, My Y. Liu, P. Murali Doraiswamy

Open source

DOI: 10.1212/wn9.0000000000000121
Published: 2026-09
Container: Neurology Open Access
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1212/wn9.0000000000000121,
  title = {Clinical Practice Outcomes With Lecanemab for Alzheimer Disease},
  author = {Andy J. Liu and Alexander A. Moghadam and Mohammad Samsul Alam and Michael W. Lutz and Amber Navarra and Sheng Luo and Laura A. Wang and Jeffrey R. Petrella and Heather Whitson and Richard J. O'Brien and Kim G. Johnson and Daniel Parker and Cynthia Beam and Michelle Sanfilippo and Heba Al-Sahlani and Sandra Cobb and My Y. Liu and P. Murali Doraiswamy},
  year = {2026},
  journal = {Neurology Open Access},
  doi = {10.1212/wn9.0000000000000121},
  url = {https://doi.org/10.1212/wn9.0000000000000121}
}

RIS

TY  - JOUR
TI  - Clinical Practice Outcomes With Lecanemab for Alzheimer Disease
AU  - Andy J. Liu
AU  - Alexander A. Moghadam
AU  - Mohammad Samsul Alam
AU  - Michael W. Lutz
AU  - Amber Navarra
AU  - Sheng Luo
AU  - Laura A. Wang
AU  - Jeffrey R. Petrella
AU  - Heather Whitson
AU  - Richard J. O'Brien
AU  - Kim G. Johnson
AU  - Daniel Parker
AU  - Cynthia Beam
AU  - Michelle Sanfilippo
AU  - Heba Al-Sahlani
AU  - Sandra Cobb
AU  - My Y. Liu
AU  - P. Murali Doraiswamy
PY  - 2026
JO  - Neurology Open Access
DO  - 10.1212/wn9.0000000000000121
UR  - https://doi.org/10.1212/wn9.0000000000000121
ER  -

APA

Liu, A. J., Moghadam, A. A., Alam, M. S., Lutz, M. W., Navarra, A., Luo, S., Wang, L. A., Petrella, J. R., Whitson, H., O'Brien, R. J., Johnson, K. G., Parker, D., Beam, C., Sanfilippo, M., Al-Sahlani, H., Cobb, S., Liu, M. Y., & Doraiswamy, P. M. (2026). Clinical Practice Outcomes With Lecanemab for Alzheimer Disease. Neurology Open Access. https://doi.org/10.1212/wn9.0000000000000121

Source records

crossref · retrieved 2026-09-27T13:25:35.547Z